News
The cancer cachexia therapeutics market is gaining traction due to the rising global cancer burden and high prevalence of cachexia in advanced-stage ...
15h
TipRanks on MSNPfizer’s Latest Study on Enfortumab Vedotin: A Boost for Urothelial Cancer TreatmentPfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc., in collaboration with Astellas Pharma Global Development, ...
Results involving the highest dose of orforglipron disappointed investors — but still bring the drug a step closer to ...
Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results